User profiles for Laura D. Hughes
Laura D. HughesScripps Research Institute Verified email at scripps.edu Cited by 1772 |
Outbreak. info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
In response to the emergence of SARS-CoV-2 variants of concern, the global scientific
community, through unprecedented effort, has sequenced and shared over 11 million genomes …
community, through unprecedented effort, has sequenced and shared over 11 million genomes …
[PDF][PDF] Emergence and rapid transmission of SARS-CoV-2 B. 1.1. 7 in the United States
The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom,
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV…
Choose your label wisely: water-soluble fluorophores often interact with lipid bilayers
Water-soluble organic fluorophores are widely used as labels in biological systems. However,
in many cases these fluorophores can interact strongly with lipid bilayers, influencing the …
in many cases these fluorophores can interact strongly with lipid bilayers, influencing the …
Why are some properties more difficult to predict than others? A study of QSPR models of solubility, melting point, and Log P
This paper attempts to elucidate differences in QSPR models of aqueous solubility (Log S),
melting point (T m ), and octanol−water partition coefficient (Log P), three properties of …
melting point (T m ), and octanol−water partition coefficient (Log P), three properties of …
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
…, LD Hughes… - Proceedings of the …, 2018 - National Acad Sciences
The chemical diversity and known safety profiles of drugs previously tested in humans make
them a valuable set of compounds to explore potential therapeutic utility in indications …
them a valuable set of compounds to explore potential therapeutic utility in indications …
[HTML][HTML] Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B. 1.1. 7 in the United States
As of January of 2021, the highly transmissible B. 1.1. 7 variant of SARS-CoV-2, which was
first identified in the United Kingdom (UK), has gained a strong foothold across the world. …
first identified in the United Kingdom (UK), has gained a strong foothold across the world. …
Outbreak. info Research Library: A standardized, searchable platform to discover and explore COVID-19 resources
Outbreak.info Research Library is a standardized, searchable interface of coronavirus
disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
disease 2019 (COVID-19) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Transcriptional profiling reveals extraordinary diversity among skeletal muscle tissues
10.7554/eLife.34613.001 Skeletal muscle comprises a family of diverse tissues with highly
specialized functions. Many acquired diseases, including HIV and COPD, affect specific …
specialized functions. Many acquired diseases, including HIV and COPD, affect specific …
Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
…, M Zeller, MG Pauthner, M McGraw, LD Hughes… - Nature …, 2022 - nature.com
Lassa fever is a severe viral hemorrhagic fever caused by a zoonotic virus that repeatedly
spills over to humans from its rodent reservoirs. It is currently not known how climate and land …
spills over to humans from its rodent reservoirs. It is currently not known how climate and land …
[PDF][PDF] Emergence of an early SARS-CoV-2 epidemic in the United States
…, G Sabino-Santos, AR Bell-Kareem, LD Hughes… - Cell, 2021 - cell.com
The emergence of the COVID-19 epidemic in the United States (US) went largely undetected
due to inadequate testing. New Orleans experienced one of the earliest and fastest …
due to inadequate testing. New Orleans experienced one of the earliest and fastest …